143 related articles for article (PubMed ID: 15382083)
1. Transgenic overexpression of a dominant negative mutant of FADD that, although counterselected during tumor progression, cooperates in L-myc-induced tumorigenesis.
Hueber AO; Bösser S; Zörnig M
Int J Cancer; 2004 Nov; 112(3):536-40. PubMed ID: 15382083
[TBL] [Abstract][Full Text] [Related]
2. p53-dependent impairment of T-cell proliferation in FADD dominant-negative transgenic mice.
Zörnig M; Hueber AO; Evan G
Curr Biol; 1998 Apr; 8(8):467-70. PubMed ID: 9550704
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of Ras, Raf and L-myc but not Bcl-2 family proteins is linked with resistance to TCR-mediated apoptosis and tumorigenesis in thymic lymphomas from TCR transgenic mice.
Kobzdej M; Matuszyk J; Strzadala L
Leuk Res; 2000 Jan; 24(1):33-8. PubMed ID: 10634643
[TBL] [Abstract][Full Text] [Related]
4. An apoptosis signaling pathway induced by the death domain of FADD selectively kills normal but not cancerous prostate epithelial cells.
Morgan MJ; Thorburn J; Thomas L; Maxwell T; Brothman AR; Thorburn A
Cell Death Differ; 2001 Jul; 8(7):696-705. PubMed ID: 11464214
[TBL] [Abstract][Full Text] [Related]
5. Wild-type p53-triggered apoptosis is inhibited by bcl-2 in a v-myc-induced T-cell lymphoma line.
Wang Y; Szekely L; Okan I; Klein G; Wiman KG
Oncogene; 1993 Dec; 8(12):3427-31. PubMed ID: 8247547
[TBL] [Abstract][Full Text] [Related]
6. Paradoxical inhibition of c-myc-induced carcinogenesis by Bcl-2 in transgenic mice.
de La Coste A; Mignon A; Fabre M; Gilbert E; Porteu A; Van Dyke T; Kahn A; Perret C
Cancer Res; 1999 Oct; 59(19):5017-22. PubMed ID: 10519417
[TBL] [Abstract][Full Text] [Related]
7. Cell type specific involvement of death receptor and mitochondrial pathways in drug-induced apoptosis.
Fulda S; Meyer E; Friesen C; Susin SA; Kroemer G; Debatin KM
Oncogene; 2001 Mar; 20(9):1063-75. PubMed ID: 11314043
[TBL] [Abstract][Full Text] [Related]
8. Apoptosis triggered by Myc-induced suppression of Bcl-X(L) or Bcl-2 is bypassed during lymphomagenesis.
Eischen CM; Woo D; Roussel MF; Cleveland JL
Mol Cell Biol; 2001 Aug; 21(15):5063-70. PubMed ID: 11438662
[TBL] [Abstract][Full Text] [Related]
9. Deregulated c-Myc prematurely recruits both Type I and II CD95/Fas apoptotic pathways associated with terminal myeloid differentiation.
Amanullah A; Liebermann DA; Hoffman B
Oncogene; 2002 Feb; 21(10):1600-10. PubMed ID: 11896589
[TBL] [Abstract][Full Text] [Related]
10. Effects of a dominant interfering mutant of FADD on signal transduction in activated T cells.
Newton K; Kurts C; Harris AW; Strasser A
Curr Biol; 2001 Feb; 11(4):273-6. PubMed ID: 11250157
[TBL] [Abstract][Full Text] [Related]
11. Theaflavins target Fas/caspase-8 and Akt/pBad pathways to induce apoptosis in p53-mutated human breast cancer cells.
Lahiry L; Saha B; Chakraborty J; Adhikary A; Mohanty S; Hossain DM; Banerjee S; Das K; Sa G; Das T
Carcinogenesis; 2010 Feb; 31(2):259-68. PubMed ID: 19969555
[TBL] [Abstract][Full Text] [Related]
12. Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1.
Zhang J; Cado D; Chen A; Kabra NH; Winoto A
Nature; 1998 Mar; 392(6673):296-300. PubMed ID: 9521326
[TBL] [Abstract][Full Text] [Related]
13. Bax accelerates tumorigenesis in p53-deficient mice.
Knudson CM; Johnson GM; Lin Y; Korsmeyer SJ
Cancer Res; 2001 Jan; 61(2):659-65. PubMed ID: 11212265
[TBL] [Abstract][Full Text] [Related]
14. A dominant interfering mutant of FADD/MORT1 enhances deletion of autoreactive thymocytes and inhibits proliferation of mature T lymphocytes.
Newton K; Harris AW; Bath ML; Smith KG; Strasser A
EMBO J; 1998 Feb; 17(3):706-18. PubMed ID: 9450996
[TBL] [Abstract][Full Text] [Related]
15. Regulation of apoptosis in mature alphabeta+CD4-CD8- antigen-specific suppressor T cell clones.
Khan Q; Penninger JM; Yang L; Marra LE; Kozieradzki I; Zhang L
J Immunol; 1999 May; 162(10):5860-7. PubMed ID: 10229821
[TBL] [Abstract][Full Text] [Related]
16. Selection for loss of p53 function in T-cell lymphomagenesis is alleviated by Moloney murine leukemia virus infection in myc transgenic mice.
Baxter EW; Blyth K; Cameron ER; Neil JC
J Virol; 2001 Oct; 75(20):9790-8. PubMed ID: 11559812
[TBL] [Abstract][Full Text] [Related]
17. Inactivation of E2f1 enhances tumorigenesis in a Myc transgenic model.
Rounbehler RJ; Rogers PM; Conti CJ; Johnson DG
Cancer Res; 2002 Jun; 62(11):3276-81. PubMed ID: 12036945
[TBL] [Abstract][Full Text] [Related]
18. p53 triggers apoptosis in oncogene-expressing fibroblasts by the induction of Noxa and mitochondrial Bax translocation.
Schuler M; Maurer U; Goldstein JC; Breitenbücher F; Hoffarth S; Waterhouse NJ; Green DR
Cell Death Differ; 2003 Apr; 10(4):451-60. PubMed ID: 12719722
[TBL] [Abstract][Full Text] [Related]
19. Bcl-xL gain of function and p19 ARF loss of function cooperate oncogenically with Myc in vivo by distinct mechanisms.
Finch A; Prescott J; Shchors K; Hunt A; Soucek L; Dansen TB; Swigart LB; Evan GI
Cancer Cell; 2006 Aug; 10(2):113-20. PubMed ID: 16904610
[TBL] [Abstract][Full Text] [Related]
20. Survival and death of prelymphomatous B-cells from N-myc/bcl-2 double transgenic mice correlates with the regulation of intracellular Ca2+ fluxes.
Zörnig M; Busch G; Beneke R; Gulbins E; Lang F; Ma A; Korsmeyer S; Möröy T
Oncogene; 1995 Nov; 11(10):2165-74. PubMed ID: 7478538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
